lenalidomide pharmascience 5mg capsule,hard
pharmascience international ltd (0000011496) lampousas 1, nicosia, 1095 - lenalidomide - capsule,hard - 5mg - lenalidomide (191732-726) 5mg
lenalidomide pharmascience 15mg capsule,hard
pharmascience international ltd (0000011496) lampousas 1, nicosia, 1095 - lenalidomide - capsule,hard - 15mg - lenalidomide (191732-726) 15mg
lenalidomide pharmascience 10mg capsule,hard
pharmascience international ltd (0000011496) lampousas 1, nicosia, 1095 - lenalidomide - capsule,hard - 10mg - lenalidomide (191732-726) 10mg
cortedal® caps 20mg/cap
demo abee 21 ΧΛΜ. ΕΘΝ.ΟΔΟΥ ΑΘΗΝΩΝ-ΛΑΜΙΑΣ, 145 68 145 68, ΚΡΥΟΝΕΡΙ 8161802 - lenalidomide - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 20mg/cap - lenalidomide 20mg - lenalidomide
cortedal® caps 15mg/cap
demo abee 21 ΧΛΜ. ΕΘΝ.ΟΔΟΥ ΑΘΗΝΩΝ-ΛΑΜΙΑΣ, 145 68 145 68, ΚΡΥΟΝΕΡΙ 8161802 - lenalidomide - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 15mg/cap - lenalidomide 15mg - lenalidomide
cortedal® caps 5mg/cap
demo abee 21 ΧΛΜ. ΕΘΝ.ΟΔΟΥ ΑΘΗΝΩΝ-ΛΑΜΙΑΣ, 145 68 145 68, ΚΡΥΟΝΕΡΙ 8161802 - lenalidomide - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 5mg/cap - lenalidomide 5mg - lenalidomide
cortedal® caps 10mg/cap
demo abee 21 ΧΛΜ. ΕΘΝ.ΟΔΟΥ ΑΘΗΝΩΝ-ΛΑΜΙΑΣ, 145 68 145 68, ΚΡΥΟΝΕΡΙ 8161802 - lenalidomide - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 10mg/cap - lenalidomide 10mg - lenalidomide
cortedal® caps 25mg/cap
demo abee 21 ΧΛΜ. ΕΘΝ.ΟΔΟΥ ΑΘΗΝΩΝ-ΛΑΜΙΑΣ, 145 68 145 68, ΚΡΥΟΝΕΡΙ 8161802 - lenalidomide - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 25mg/cap - lenalidomide 25mg - lenalidomide
thiotepa riemser
esteve pharmaceuticals gmbh - θειοτέπα - hematopoietic stem cell transplantation; neoplasms - Αντινεοπλασματικοί παράγοντες - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
lenalidomide/rafarm caps 25mg/cap
rafarm a.e.b.e. ΚΟΡΙΝΘΟΥ 12, 15451 Ν. ΨΥΧΙΚΟ 6776550, 6747086 - lenalidomide - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 25mg/cap - lenalidomide 25mg - lenalidomide